Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Innate immunity serves as the first line of defence against invading pathogens such as bacteria and viruses. Toll-like receptors (TLRs) are examples of innate immune receptors, which sense specific molecular patterns from pathogens and activate immune responses. TLR9 recognizes bacterial and viral DNA containing the cytosine-phosphate-guanine (CpG) dideoxynucleotide motif. The molecular basis by which CpG-containing DNA (CpG-DNA) elicits immunostimulatory activity via TLR9 remains to be elucidated. Here we show the crystal structures of three forms of TLR9: unliganded, bound to agonistic CpG-DNA, and bound to inhibitory DNA (iDNA). Agonistic-CpG-DNA-bound TLR9 formed a symmetric TLR9-CpG-DNA complex with 2:2 stoichiometry, whereas iDNA-bound TLR9 was a monomer. CpG-DNA was recognized by both protomers in the dimer, in particular by the amino-terminal fragment (LRRNT-LRR10) from one protomer and the carboxy-terminal fragment (LRR20-LRR22) from the other. The iDNA, which formed a stem-loop structure suitable for binding by intramolecular base pairing, bound to the concave surface from LRR2-LRR10. This structure serves as an important basis for improving our understanding of the functional mechanisms of TLR9.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Structural studies recently described two different TLR9i sequences that formed stem-loop structures that fit snugly into the interior of the ring structure of TLR9, preventing dimerization and activation (21).”
From Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses (2021) · cites this paper as [21]
In the citing paper
“the binding site of TLR9i oligonucleotides on TLR9 partially overlapped with that of CpG DNA, and the TLR9i oligonucleotide tested possessed higher binding affinity for TLR9 than CpG DNA”
From Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses (2021) · cites this paper as [21]
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
PHENIX : building new software for automated crystallographic structure determination
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., & Terwilliger, T. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016657 · Cited by 4,361
Schuck, P. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76713-0 · Cited by 3,868
Cited by
Toll-like Receptors and the Control of Immunity
Fitzgerald, K. A., & Kagan, J. C. (2020) · Cell · doi:10.1016/j.cell.2020.02.041 · Cited by 2,168
Chemistry, structure and function of approved oligonucleotide therapeutics
Egli, M., & Manoharan, M. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad067 · Cited by 828
Decoding Toll-like receptors: Recent insights and perspectives in innate immunity
Kawai, T., Ikegawa, M., Ori, D., & Akira, S. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.004 · Cited by 528
Recognition of Endogenous Nucleic Acids by the Innate Immune System
Roers, A., Hiller, B., & Hornung, V. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.002 · Cited by 541
Zhang, Z., Ohto, U., Shibata, T., Krayukhina, E., Taoka, M., Yamauchi, Y., Tanji, H., Isobe, T., Uchiyama, S., Miyake, K., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.09.011 · Cited by 461
“The Z-loop of TLR9 is positioned at the concave surface of the C-terminal fragment and is not associated with ligand recognition (Ohto et al., 2015).”
InfluentialDetection of Microbial Infections Through Innate Immune Sensing of Nucleic Acids
Tan, X., Sun, L., Chen, J., & Chen, Z. J. (2018) · Annual Review of Microbiology · doi:10.1146/annurev-micro-102215-095605 · Cited by 443
Drugging Membrane Protein Interactions
Yin, H., & Flynn, A. D. (2016) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-092115-025322 · Cited by 339
“Crystal structures of both unliganded and liganded TLR8 ectodomains indicate that conformational changes after ligand binding include both a ring rotation and a hinge motion, bringing together the C termini of the ectodomains; structures of TLR9 with activating and inhibitory DNA show how ligand binding might induce T…”
BackgroundInfluentialPattern recognition receptors: function, regulation and therapeutic potential
Chen, R., Zou, J., Chen, J., Zhong, X., Kang, R., & Tang, D. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02264-1 · Cited by 301
Regulation of the nucleic acid-sensing Toll-like receptors
Lind, N. A., Rael, V. E., Pestal, K., Liu, B., & Barton, G. M. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00577-0 · Cited by 307
Hartmann, G. (2017) · Advances in Immunology · doi:10.1016/bs.ai.2016.11.001 · Cited by 285
“Activation of TLR9 signaling is preceded by dimer formation where two CpG DNA molecules symmetrically bind two TLR9 molecules (Ohto et al., 2015).”
BackgroundRecent clinical trends in Toll‐like receptor targeting therapeutics
Anwar, M. A., Shah, M., Kim, J., & Choi, S. (2019) · Medicinal Research Reviews · doi:10.1002/med.21553 · Cited by 275
“CpG‐DNA binding with TLR9 is symmetric and they form a stoichiometric complex of 2:2, as DNA is recognized by both TLR9 monomers, particularly via the amino‐terminal fragment (LRRNT–LRR10) from one protomer and the carboxy‐terminal fragment (LRR20–LRR22) from the other.(142) CpG‐DNA‐based TLR9 inhibition is mediated b…”
BackgroundToll-Like Receptors: General Molecular and Structural Biology
Behzadi, P., García-Perdomo, H. A., & Karpiński, T. M. (2021) · Journal of Immunology Research · doi:10.1155/2021/9914854 · Cited by 251
Molecular Mechanisms of mtDNA-Mediated Inflammation
De Gaetano, A., Solodka, K., Zanini, G., Selleri, V., Mattioli, A. V., Nasi, M., & Pinti, M. (2021) · Cells · doi:10.3390/cells10112898 · Cited by 230
Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses
Chan, Y. K., Wang, S. K., Chu, C. J., Copland, D. A., Letizia, A. J., Costa Verdera, H., Chiang, J. J., Sethi, M., Wang, M. K., Neidermyer, W. J., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd3438 · Cited by 215
DNA Sensing in the Innate Immune Response
Briard, B., Place, D. E., & Kanneganti, T.-D. (2020) · Physiology · doi:10.1152/physiol.00022.2019 · Cited by 211
Programmable icosahedral shell system for virus trapping
Sigl, C., Willner, E. M., Engelen, W., Kretzmann, J. A., Sachenbacher, K., Liedl, A., Kolbe, F., Wilsch, F., Aghvami, S. A., Protzer, U., et al. (2021) · Nature Materials · doi:10.1038/s41563-021-01020-4 · Cited by 208
Kabe, Y., Nakane, T., Koike, I., Yamamoto, T., Sugiura, Y., Harada, E., Sugase, K., Shimamura, T., Ohmura, M., Muraoka, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms11030 · Cited by 171
Self-citationLi, Y., Li, Y., Cao, X., Jin, X., & Jin, T. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.50 · Cited by 174
Fine tuning of CpG spatial distribution with DNA origami for improved cancer vaccination
Zeng, Y. C., Young, O. J., Wintersinger, C. M., Anastassacos, F. M., MacDonald, J. I., Isinelli, G., Dellacherie, M. O., Sobral, M., Bai, H., Graveline, A. R., et al. (2024) · Nature Nanotechnology · doi:10.1038/s41565-024-01615-3 · Cited by 169
“10).”
InfluentialOhto, U., Ishida, H., Shibata, T., Sato, R., Miyake, K., & Shimizu, T. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.013 · Cited by 164
Self-citationMolecular basis of mycobacterial survival in macrophages
Awuh, J. A., & Flo, T. H. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2422-8 · Cited by 185
“TLR9 is expressed by pDCs, macrophages, and B cells, and recognizes bacterial and viral DNA that is rich in unmethylated CpG DNA motifs, as well as synthetic CpG oligonucleotides [7, 143].”
BackgroundTranslating nucleic acid-sensing pathways into therapies
Junt, T., & Barchet, W. (2015) · Nature reviews. Immunology · doi:10.1038/nri3875 · Cited by 166
“For example, the co-crystal structures of recombinant cGAS, STING, RIG-I, TLR8 and TLR9 with their ligands have recently been solved 18,19,28,51,56,113–116 and enable virtual library screens for compounds that act on the respective target.”
Nucleic acid-sensing TLRs: trafficking and regulation
Majer, O., Liu, B., & Barton, G. M. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.10.003 · Cited by 154
Mukherjee, S., Patra, R., Behzadi, P., Masotti, A., Paolini, A., & Sarshar, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1244345 · Cited by 166
Lu, Y., Chan, W., Ko, B. Y., VanLang, C. C., & Swartz, J. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510533112 · Cited by 148
Dongye, Z., Li, J., & Wu, Y. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01876-6 · Cited by 149
Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy
Iribarren, K., Bloy, N., Buqué, A., Cremer, I., Eggermont, A., Fridman, W. H., Fucikova, J., Galon, J., Špíšek, R., Zitvogel, L., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1088631 · Cited by 131
Toll-Like Receptor 9 Agonists in Cancer
Karapetyan, L., Luke, J. J., & Davar, D. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s247050 · Cited by 147
“However, following ligand binding, proteolytically cleaved TLR9 dimerizes forming a homodimer.(90,91,93) TLR9 preferentially detects unmethylated CpG oligodinucleotides (ODN) with a species-specific preference for hexamer CpG motifs (human 5′-GTCGTT-3 vs.”
BackgroundActivation and Regulation of DNA-Driven Immune Responses
Paludan, S. R. (2015) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00061-14 · Cited by 124
Spatially Controlled Activation of Toll-like Receptor 9 with DNA-Based Nanomaterials
Comberlato, A., Koga, M. M., Nüssing, S., Parish, I. A., & Bastings, M. M. C. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c00275 · Cited by 132
Evolutionary History of the Toll-Like Receptor Gene Family across Vertebrates
Liu, G., Zhang, H., Zhao, C., & Zhang, H. (2020) · Genome Biology and Evolution · doi:10.1093/gbe/evz266 · Cited by 117
Challenges Posed by Immune Responses to AAV Vectors: Addressing Root Causes
Hamilton, B. A., & Wright, J. F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.675897 · Cited by 117
Zuliani-Alvarez, L., Marzeda, A. M., Deligne, C., Schwenzer, A., McCann, F. E., Marsden, B. D., Piccinini, A. M., & Midwood, K. S. (2017) · Nature Communications · doi:10.1038/s41467-017-01718-7 · Cited by 115
Structural and functional understanding of the toll‐like receptors
Asami, J., & Shimizu, T. (2021) · Protein Science · doi:10.1002/pro.4043 · Cited by 129
“A study of full-length TLR9 in cell suggested that TLR9 exists as a pre-formed homodimer,(30) though structural work of TLR9 ECD shows a monomer.(29) The discrepancy can be overcome by the structural study using TLRs embedded in the membrane, reflecting the physiological condition.”
BackgroundSelf-citationNucleic acid‐sensing TLR s and autoimmunity: novel insights from structural and cell biology
Pelka, K., Shibata, T., Miyake, K., & Latz, E. (2016) · Immunological Reviews · doi:10.1111/imr.12375 · Cited by 110
Self-citationMechanisms controlling nucleic acid-sensing Toll-like receptors
Miyake, K., Shibata, T., Ohto, U., Shimizu, T., Saitoh, S.-I., Fukui, R., & Murakami, Y. (2018) · International Immunology · doi:10.1093/intimm/dxy016 · Cited by 111
Self-citationModulation of toll-like receptor signaling by antimicrobial peptides
Lee, E. Y., Lee, M. W., & Wong, G. C. L. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.02.002 · Cited by 123
Signaling Through Nucleic Acid Sensors and Their Roles in Inflammatory Diseases
Okude, H., Ori, D., & Kawai, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.625833 · Cited by 104
“TLR9 forms a complex with CpG DNA at a 2:2 ratio (53).”
BackgroundMolecular and Structural Basis of DNA Sensors in Antiviral Innate Immunity
Zahid, A., Ismail, H., Li, B., & Jin, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613039 · Cited by 100
“org 5 dimerization of TLR9; therefore, Z-loop processing, if not necessary for binding with DNA, is essential for mediating the CpG-DNA-induced dimerization of TLR9 (86).”
BackgroundInfluentialAbdul-Cader, M. S., Amarasinghe, A., & Abdul-Careem, M. F. (2016) · Archives of Virology · doi:10.1007/s00705-016-2904-x · Cited by 99
Durán-Flores, D., & Heil, M. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.10.010 · Cited by 101
Cheng, C., Tan, J., Qian, W., Zhang, L., & Hou, X. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.08.017 · Cited by 86
Meliţ, L. E., Mărginean, C. O., Mărginean, C. D., & Săsăran, M. O. (2019) · Journal of Immunology Research · doi:10.1155/2019/8197048 · Cited by 89
Release from UNC93B1 reinforces the compartmentalized activation of select TLRs
Majer, O., Liu, B., Woo, B. J., Kreuk, L. S. M., Dis, E. S. V., & Barton, G. M. (2019) · Nature · doi:10.1038/s41586-019-1611-7 · Cited by 93
A tissue level atlas of the healthy human virome
Kumata, R., Ito, J., Takahashi, K., Suzuki, T., & Sato, K. (2020) · BMC Biology · doi:10.1186/s12915-020-00785-5 · Cited by 92
“TTV is a single-stranded DNA virus, and human Toll-like receptor 9 is a PRR that senses single-stranded DNA and induces IFN production [56, 57].”
BackgroundXia, P., Wu, Y., Lian, S., Li, Y., Meng, X., Duan, Q., & Zhu, G. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11406-8 · Cited by 90
Host Response to Biomaterials for Cartilage Tissue Engineering: Key to Remodeling
Fu, W. E., Liu, S., Chen, M., Tian, G., Zha, K., Yang, Z., Jiang, S., Li, M., Sui, X., Chen, Z., et al. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.664592 · Cited by 83
Lurje, I., Werner, W., Mohr, R. U., Roderburg, C., Tacke, F., & Hammerich, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.650486 · Cited by 85
Structural basis for specific recognition of single-stranded RNA by Toll-like receptor 13
Song, W., Wang, J., Zhifu, H., Zhang, Y., Zhang, H., Wang, W., Chang, J., 夏炳树, Fan, S., Zhang, D., et al. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3080 · Cited by 78
Structures and recognition modes of toll‐like receptors
Gao, D., & Li, W. (2016) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25179 · Cited by 89
Mitochondrial DNA signals driving immune responses: Why, How, Where?
Giordano, L., Ware, S. A., Lagranha, C. J., & Kaufman, B. A. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02042-0 · Cited by 86
“TLR9 homodimerizes when the CpG motifs in the DNA act like a bridge binding to the LRR of the cleaved N-terminal fragment and to the LRR of the C-terminal fragment of an adjacent TLR9 [263].”
Zheng, W. J., Xu, Q., Zhang, Y., Xiaofei, E., Gao, W., Zhang, M., Zhai, W., Rajkumar, R. S., & Liu, Z. (2020) · Virology Journal · doi:10.1186/s12985-020-01463-2 · Cited by 74
Alternative splicing regulates stochastic NLRP3 activity
Hoss, F., Mueller, J. L., Rojas Ringeling, F., Rodriguez-Alcazar, J. F., Brinkschulte, R., Seifert, G., Stahl, R., Broderick, L., Putnam, C. D., Kolodner, R. D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11076-1 · Cited by 69
Goodwin, T. J., & Huang, L. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.03.067 · Cited by 68
“The most reported adjuvants over the past two decades in the field consist of CpG and poly(I:C) which targets toll-like receptors (TLRs) located on the cell membrane or endosome (3).”
BackgroundSources of Pathogenic Nucleic Acids in Systemic Lupus Erythematosus
Mustelin, T., Lood, C., & Giltiay, N. V. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01028 · Cited by 78
Quantification of CpG motifs in rAAV genomes: Avoiding the toll
Wright, J. F. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.07.006 · Cited by 65
“RF3 modifies RF2 to incorporate known immune-stimulatory (S4) and -inhibitory (I4) tetranucleotide CpG motifs reported by vaccine research aiming to enhance cellular immune responses using oligonucleotide adjuvants.(3,13,14) The S4 and I4 CpG motifs were enumerated and summed for each test DNA sequence.”
BackgroundSmall-Molecule Targets in Immuno-Oncology
Dhanak, D., Edwards, J. P., Nguyen, A., & Tummino, P. J. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.08.019 · Cited by 67
“…resiquimod and other synthetic small-molecule ligands (Tanji et al., 2013; Ohto et al., 2014; Zhang et al., 2016) and the TLR9 apo and ligand-bound structures (Ohto et al., 2015), prospects for the rational design of more potent and selective ligands for these receptors appear much more promising.”
BackgroundChen, C., Ai, Q., Chu, S., Zhang, Z., & Chen, N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.103 · Cited by 69
Zhu, X., Huang, H., & Жао, Л. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.856118 · Cited by 79
Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions
Myint, M., Oppedisano, F., De Giorgi, V., Kim, B.-M., Marincola, F. M., Alter, H. J., & Nesci, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04627-0 · Cited by 61
“…to the endosome after stimulation by hypomethylated CpG motifs found in bacteria and mtDNA released into the cytosol in conditions of MD. Dimerization of TLR9 is required for activation and occurs through the recognition of two TLR9 protomers binding CpG motifs from different DNA molecules [72].”
BackgroundWen, L., Zhang, B., Wu, X., Liu, R., Fan, H., Han, L., Zhang, Z., Ma, X., Chu, C., & Shi, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1093208 · Cited by 76
Selectivity of Human TLR9 for Double CpG Motifs and Implications for the Recognition of Genomic DNA
Pohar, J., Yamamoto, C., Fukui, R., Cajnko, M. M., Miyake, K., Jerala, R., & Benčina, M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600757 · Cited by 64
Self-citationRAGE Enhances TLR Responses through Binding and Internalization of RNA
Bertheloot, D., Naumovski, A. L., Langhoff, P., Horvath, G. L., Jin, T., Xiao, T. S., Garbi, N., Agrawal, S., Kolbeck, R., & Latz, E. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502169 · Cited by 57
Zhang, X., Wu, F., Men, K., Huang, R., Zhou, B., Zhang, R., Zou, R., & Yang, L. (2018) · Nanoscale Research Letters · doi:10.1186/s11671-018-2661-8 · Cited by 59
Maeda, K., & Akira, S. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.003 · Cited by 62
Autoinhibition and relief mechanism by the proteolytic processing of Toll-like receptor 8
Tanji, H., Ohto, U., Motoi, Y., Shibata, T., Miyake, K., & Shimizu, T. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516000113 · Cited by 55
Self-citationDuplicated TLR5 of zebrafish functions as a heterodimeric receptor
Voogdt, C. G. P., Wagenaar, J. A., & van Putten, J. P. M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719245115 · Cited by 57
Shimizu, T. (2017) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2017.05.010 · Cited by 57
Self-citationMitochondrial DNA as inflammatory DAMP: a warning of an aging immune system?
Zanini, G., Selleri, V., Doménech, S. L., Malerba, M., Nasi, M., Mattioli, A. V., & Pinti, M. (2023) · Biochemical Society Transactions · doi:10.1042/bst20221010 · Cited by 62
Shah, S. B., Carlson, C. R., Lai, K., Zhong, Z., Marsico, G., Lee, K. M., Vélez, N. E. F., Abeles, E. B., Allam, M., Hu, T., et al. (2023) · Nature Materials · doi:10.1038/s41563-023-01495-3 · Cited by 55
Qu, Y., Rose, R. D., Kim, C., Zhou, J., Lin, Z., Ju, Y., Bhangu, S. K., Cortez‐Jugo, C., Cavalieri, F., & Caruso, F. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202214935 · Cited by 49
Self-assembling DNA hydrogel-based delivery of immunoinhibitory nucleic acids to immune cells
Nishida, Y., Ohtsuki, S., Araie, Y., Umeki, Y., Endo, M., Emura, T., Hidaka, K., Sugiyama, H., Takahashi, Y., Takakura, Y., et al. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.08.004 · Cited by 52
The evolution of bat nucleic acid‐sensing Toll‐like receptors
Escalera‐Zamudio, M., Mendoza, M. L. Z., Rubio, E. L., Anaya, E. R., Méndez-Ojeda, M. L., Arias, C. F., & Greenwood, A. D. (2015) · Molecular Ecology · doi:10.1111/mec.13431 · Cited by 55
“…using the SWISSMODEL automated system (Biasini et al. 2014) using the crystal structures of the unliganded human TLR 3 and 8 and of the horse TLR 9 as templates (File S1, Supporting information under Dryad data package) (Bell et al. 2005; Choe et al. 2005; Tanji et al. 2013; Ohto et al. 2015).”
BackgroundMethodInfluentialMiyamoto, N., Mochizuki, S., Fujii, S., Yoshida, K., & Sakurai, K. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00675 · Cited by 50
Short single-stranded DNA degradation products augment the activation of Toll-like receptor 9
Pohar, J., Lainšček, D., Ivičak‐Kocjan, K., Cajnko, M. M., Jerala, R., & Benčina, M. (2017) · Nature Communications · doi:10.1038/ncomms15363 · Cited by 57
“Based on the crystal structure of the mTLR9-ODN complex, the 12 nt-long ODN binds to the mTLR9 ectodomain with a 2:2 stoichiometry 4 .”
Discrimination Between Self and Non-Self-Nucleic Acids by the Innate Immune System
(2019) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2018.08.004 · Cited by 49
Santa, P., Garreau, A., Serpas, L., Ferrière, A., Blanco, P., Soni, C., & Sisirak, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.629922 · Cited by 71
“TLR9 preferentially recognizes unmethylated CpG dinucleotides in dsDNA sequences (16, 17), while TLR3 is activated by 3948bp of dsRNA (18).”
BackgroundCyprinid‐specific duplicated membrane TLR5 senses dsRNA as functional homodimeric receptors
Liao, Z., Yang, C., Jiang, R., Zhu, W., Zhang, Y., & Su, J. (2022) · EMBO Reports · doi:10.15252/embr.202154281 · Cited by 51
Zang, J., Zheng, M., Cao, X., Zhang, Y., Zhang, Y.-F., Gao, X.-Y., Cao, Y., Shi, M., Han, H., & Liang, L. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00598-7 · Cited by 51
Ectodomain Architecture Affects Sequence and Functional Evolution of Vertebrate Toll-like Receptors
Wang, J., Zhang, Z., Liu, J., Zhao, J., & Yin, D. (2016) · Scientific Reports · doi:10.1038/srep26705 · Cited by 56
Structural characterization and evolutionary analysis of fish-specific TLR27
Wang, J., Zhang, Z., Liu, J., Li, F., Chang, F., Fu, H., Zhao, J., & Yin, D. (2015) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2015.06.017 · Cited by 49
Franzo, G., Tucciarone, C. M., Cecchinato, M., & Drigo, M. (2017) · Molecular Phylogenetics and Evolution · doi:10.1016/j.ympev.2017.05.019 · Cited by 48
Species-Specific Minimal Sequence Motif for Oligodeoxyribonucleotides Activating Mouse TLR9
Pohar, J., Lainšček, D., Fukui, R., Yamamoto, C., Miyake, K., Jerala, R., & Benčina, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500600 · Cited by 45
“horse and mouse TLR9 with bound B class short ODNs (7).”
BackgroundInfluentialSelf-citationZhang, Z., Ohto, U., & Shimizu, T. (2017) · FEBS Letters · doi:10.1002/1873-3468.12749 · Cited by 52
Self-citationTargeting nuclear acid-mediated immunity in cancer immune checkpoint inhibitor therapies
Chen, M., Hu, S., Li, Y., Jiang, T., Jin, H., & Feng, L. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00347-9 · Cited by 51
Sequence-Specific Sensing of Nucleic Acids
Vabret, N., Bhardwaj, N., & Greenbaum, B. D. (2017) · Trends in Immunology · doi:10.1016/j.it.2016.10.006 · Cited by 45
Wu, Y., Wen, H., Bernstein, Z. J., Hainline, K. M., Blakney, T. S., Congdon, K. L., Snyder, D. J., Sampson, J. H., Sanchez-Perez, L. A., & Collier, J. H. (2022) · Science Advances · doi:10.1126/sciadv.abm7833 · Cited by 51
Immune functions of pattern recognition receptors in Lepidoptera
Zhao, L., Niu, J., Feng, D., Wang, X., & Zhang, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1203061 · Cited by 61
Tripathi, A., Bartosh, A., Whitehead, C., & Pillai, A. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02189-7 · Cited by 48
“CpG motifs and therefore, the cell-free DNA released from mitochondria which is rich in unmethylated can trigger in fl ammation via TLR9 [38]. mtDNA to TLR9 through a sequence speci fi c to the N-terminal of the C-shaped leucine-rich repeat region of TLR9 [118].”
BackgroundRegulation of migration and invasion by Toll-like receptor-9 signaling network in prostate cancer
Luo, Y., Jiang, Q., Wu, J., Qiu, J.-G., Zhang, W., Mei, X.-L., Shi, Z., & Di, J. (2015) · Oncotarget · doi:10.18632/oncotarget.4197 · Cited by 48
“com/oncotarget CpG dinucleotide motifs (CpG motifs) [8, 9].”
Source of CpG Depletion in the HIV-1 Genome
Alinejad‐Rokny, H., Anwar, F., Waters, S. A., Davenport, M. P., & Ebrahimi, D. (2016) · Molecular Biology and Evolution · doi:10.1093/molbev/msw205 · Cited by 43
“…receptors (TLR) that identify and/or target CpG within foreign genomes (Bauer et al. 2001; Boehme and Compton 2004; Greenbaum et al. 2008, 2009; Chang and Altfeld 2009; Jimenez-Baranda et al. 2011; Pezda et al. 2011; Ohto et al. 2015), thus putting pressure on HIV-1 to reduce its CpG level.”
BackgroundNucleic Acid Sensing by Toll-Like Receptors in the Endosomal Compartment
Miyake, K., Shibata, T., Fukui, R., Sato, R., Saitoh, S.-I., & Murakami, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.941931 · Cited by 51
“Because TLR9 has two binding sites, ssDNA fragment binds to a pair of TLR9 molecules, leading to the formation of a TLR9 dimer with two ssDNA fragments (14).”
BackgroundSelf-citationMolecular mechanisms of nonself nucleic acid recognition by the innate immune system
Mann, C. C. D. O., & Hornung, V. (2021) · European Journal of Immunology · doi:10.1002/eji.202049116 · Cited by 48
Insights into innate immune activation via PS-ASO–protein–TLR9 interactions
Pollak, A. J., Zhao, L., Vickers, T. A., Huggins, I. J., Liang, X., & Crooke, S. T. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac618 · Cited by 48
Leleux, J. A., Pradhan, P., & Roy, K. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.073 · Cited by 46
Arsiwala, A., Castro, A., Frey, S. J., Stathos, M., & Kane, R. S. (2019) · Chemistry - An Asian Journal · doi:10.1002/asia.201801677 · Cited by 51
Mitochondrial DAMPs: Key mediators in neuroinflammation and neurodegenerative disease pathogenesis
Yu, H., Ren, K., Jin, Y., Zhang, L., Liu, H., Huang, Z., Zhang, Z., Chen, X., Yang, Y., & Wei, Z. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110217 · Cited by 51
Balancing Inflammation: Computational Design of Small-Molecule Toll-like Receptor Modulators
Murgueitio, M. S., Rakers, C., Frank, A., & Wolber, G. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.10.007 · Cited by 42
Lipids that directly regulate innate immune signal transduction
Barnett, K. C., & Kagan, J. C. (2019) · Innate Immunity · doi:10.1177/1753425919852695 · Cited by 46
Hou, X., Hao, X., Zheng, M., Xu, C., Wang, J., Zhou, R., & Tian, Z. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.111 · Cited by 41
Metadata
- Authors
- Ohto, U., Shibata, T., Tanji, H., Ishida, H., Krayukhina, E., Uchiyama, S., Miyake, K., & Shimizu, T.
- Affiliations
- The University of Tokyo (JP)
- Japan Science and Technology Agency (JP)
- The University of Osaka (JP)
- Institute of Medical Science, The University of Tokyo (JP)
- Corresponding author
- Shimizu, Toshiyuki
- Venue
- Nature
- Published
- 2015-02-09
- Volume
- 520
- Issue
- 7549
- Pages
- 702-705
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2129961630
- Semantic Scholar
- 385253b727f67c70b401c7d39f56cdcb8ddf5dc1
- Cited by
- 377
- References
- 34
- Citations by year
- 2026: 30 · 2025: 30 · 2024: 32 · 2023: 36 · 2022: 33 · 2021: 31 · 2020: 33 · 2019: 28 · 2018: 36 · 2017: 30 · 2016: 43 · 2015: 15
- FWCI
- 20.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Japan Society for the Promotion of Science (25121722, 25253032, 25291010)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- TLR9, CpG DNA, innate immunity, TLR9 activation, crystal structure, ligand binding, leucine-rich repeats, stem-loop structure, intramolecular base pairing
- MeSH terms
- Animals, Base Sequence, DNA, Humans, Ligands, Models, Molecular, Nucleic Acid Conformation, Structure-Activity Relationship, Protein Structure, Tertiary, Crystallography, X-Ray, CpG Islands, Toll-Like Receptor 9
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.